MLchartDataset catalogue

Bendeka

Term · Oncology and biomedicine · MLC-T-ONC-000982

A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendeka damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, bendamustine hydrochloride, and Treanda.

Table 1. Record
IdentifierMLC-T-ONC-000982
FieldOncology and biomedicine
SynonymsBelrapzo; bendamustine hydrochloride; Treanda
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000982",
  "term": "Bendeka",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendeka damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, bendamustine hydrochloride, and Treanda.",
  "synonyms": [
    "Belrapzo",
    "bendamustine hydrochloride",
    "Treanda"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/bendeka/"
}

Record 3,424 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.